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ABSTRACT 26 
Lactating cow diets were supplemented with high oleic acid sunflower oil over two production 27 
periods spanning two years, to modify the milk fat, partially replacing saturated fatty acids 28 
(SFA) with cis-monounsaturated fatty acids (MUFA). The resulting milk was used for ultra-29 
high temperature (UHT) milk, butter and Cheddar cheese production, and fatty acid profiles 30 
were compared with those of conventionally-produced products. Fat from products made with 31 
modified milk had lower SFA and higher cis- and trans-MUFA concentrations than that of 32 
conventional products. This was consistent over production periods, demonstrating that this 33 
food chain approach could be adopted on a wider scale.  34 
 35 
Keywords: Bovine milk, fatty acids, lipids, milk processing 36 
 37 
INTRODUCTION 38 
Milk and dairy products are a major source of fat and fatty acids (FA) in the UK adult diet, 39 
contributing to 18 % total fat, 28 % saturated fatty acid (SFA), 38 % trans fatty acid (TFA) 40 
intake (Bates et al., 2016) and 12 % cis-monounsaturated fatty acid (MUFA) intake (Hobbs, 41 
personal communication). At the population level total SFA intake exceeds current 42 
recommendations (12.1 % total energy intake [EI]; Bates et al., 2016 vs <10 % total EI; WHO, 43 
2010). A reduction in dietary TFA from industrially hydrogenated food sources has led to an 44 
increase in the contribution of these FAs from dairy products but overall TFA consumption has 45 
declined (Henderson et al., 2003; Bates et al., 2016) and is below the maximum recommended 46 
intake of 2 % total energy (SACN, 2007). 47 
 48 
Replacing dietary SFA with cis-MUFA and cis-polyunsaturated fatty acids (PUFA) has been 49 
shown to reduce cardiovascular disease (CVD) risk factors, including fasting serum total and 50 
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low density lipoprotein-cholesterol concentrations and total:high density lipoprotein-51 
cholesterol ratio (Vafeiadou et al., 2015).  The most effective means of replacing SFA with 52 
unsaturated FA in milk fat is by altering the dairy cow diet (Kliem & Shingfield, 2016). Due 53 
to the more extensive rumen biohydrogenation of dietary PUFA compared with cis-MUFA 54 
(Shingfield et al., 2008), and the greater proportion of cis-MUFA compared with PUFA in milk 55 
fat (Kliem et al., 2013), replacement of SFA with cis-MUFA offers a greater potential for SFA 56 
reduction in milk fat. Relatively few studies have assessed the impact of consuming dairy 57 
products modified using this dietary strategy (replacing milk SFA with either MUFA or PUFA) 58 
on cardiovascular health outcomes in humans (Livingstone et al., 2012). Some of these studies 59 
used only butter as the test dairy product, thus not representing the nutritional composition of 60 
a range of dairy products and food matrices (Livingstone et al., 2012). Two studies (Noakes et 61 
al., 1996; Seidel et al., 2005) included a range of dairy products modified by changing the cow 62 
diet in their interventions, but the human interventions only lasted for relatively short periods 63 
of time (up to three weeks) and involved small numbers of participants. It is not known whether 64 
the FA composition of milk and dairy products produced by changing the cow diet would be 65 
consistent over longer periods of time, especially as milk FA response to dietary oilseeds 66 
appears to vary according to differences in other dietary nutrients (Lerch et al., 2012a). 67 
 68 
The main objectives of this study were twofold; firstly to identify whether UHT milk, butter 69 
and Cheddar cheese could be produced with the same FA profile over a two-year period, from 70 
milk produced using an oleic-acid rich supplementation strategy. This utilised a high oleic acid 71 
(cis-9 18:1) sunflower oil to maximise the replacement of SFA with MUFA, after previous 72 
research highlighted the potential of these oils (Loor et al., 2002; Kliem et al., 2011). The 73 
second objective was to compare the FA composition of the modified dairy products with 74 
conventional products containing FA profiles typical of UK retail milk during winter months 75 
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(average SFA 71.5 g/100 g total FA, cis-MUFA 21.2 g/100 g FA; Kliem et al., 2013), and for 76 
this to be consistent across products. 77 
 78 
MATERIALS AND METHODS 79 
 80 
Production of modified milk 81 
Between December 2013 and May 2015, groups of multiparous Holstein-Friesian cows were 82 
fed a diet which resulted in modified milk. For the purposes of the human intervention trial that 83 
this study formed part of (Markey et al., 2017), milk production was divided into two periods; 84 
Production period 1 (P1) took place between December 2013 and September 2014, involving 85 
a total of 58 cows (mean ± standard error parity 4.0 ± 0.12; milk yield at start 35.0 ± 0.77 86 
litres/day, and days in lactation 181 ± 7.7), producing a total of approximately 12,500 litres of 87 
milk which were used to produce modified UHT milk, butter and cheese. Production period 2 88 
(P2) took place between November 2014 and May 2015, involving a total of 41 cows (mean ± 89 
standard error parity 4.0 ± 0.12; milk yield at start 33.4 ± 0.91 litres/day, and days in lactation 90 
205 ± 7.2) producing a total of 16,350 litres of milk. Cows selected to produce modified milk 91 
were adapted to a total mixed ration (TMR) diet, an example of which is presented in Table 1. 92 
Dietary ingredients were replicated for each production batch. The diet had a 93 
forage:concentrate ratio of 50:50 on a DM basis, with the forage consisting of maize silage, 94 
grass silage, grass hay and wheat straw. The diet was supplemented with 43 g/kg dry matter 95 
(DM) of high oleic acid sunflower oil (AAK Ltd., Hull, East Yorkshire, HU9 5PX, UK) so that 96 
it would supply a cow consuming 23 kg DM per day with 1 kg oil. The cows were adapted to 97 
this diet for a period of four weeks before any milk collection was made. Following this 98 
adaptation period, subsamples of modified milk were taken and preserved with potassium 99 
dichromate (1 mg/ml; Lactabs; Thompson and Capper, Runcorn, UK) for milk compositional 100 
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analysis. A further subsample was frozen to measure the FA profile prior to product 101 
manufacture. 102 
 103 
Manufacture of dairy products 104 
UHT Milk Processing. UHT milk, i.e. both modified and conventionally-produced milk, was 105 
produced three times, twice during P1 and once during P2. The first P1 production run was 106 
carried out at Reaseheath College (Nantwich, UK) with the remaining production runs carried 107 
out at Frampton’s Ltd (Shepton Mallet Somerset, UK). Raw conventional milk was provided 108 
by Arla Foods UK (Taw Valley Creamery, North Tawton, UK), and represented retail milk 109 
with a typical UK winter dairy FA profile. Conventional milk was standardised to match the 110 
fat content of the modified milk using skimmed milk provided by A.E Rodda & Son Ltd., 111 
(Redruth, Cornwall, UK), for the purposes of the human intervention study. Raw conventional 112 
milk was pumped to a tank and skimmed milk, at the level required to match the low SFA milk 113 
fat content, was added. The milk was agitated in the tank for 5 minutes and a sample removed 114 
and analysed to ensure the fat content was correct. UHT processing was carried out in a pilot 115 
scale UHT plant. The milk was preheated to 85ºC using a plate heat exchanger and 116 
homogenised. The milk was then heated to 142ºC for 5 seconds using direct steam infusion and 117 
cooled to 15ºC and aseptically packaged into 5 kg aseptic bags (Reaseheath) or 330 ml aseptic 118 
cartons (Framptons). All UHT milk was stored at 4ºC until required. 119 
 120 
Cheddar cheese processing. Conventional Cheddar cheese was provided by Arla Foods UK 121 
(Taw Valley Creamery), to represent retail mild (3 month) Cheddar cheese with a typical UK 122 
winter dairy FA profile. Modified Cheddar cheese was manufactured at the University of 123 
Reading Pilot Plant (Reading, UK). Both cheese types were produced only once during P1 and 124 
P2. The processing parameters for the modified cheese were selected to mimic the commercial 125 
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process used at Arla. Modified raw milk was pasteurised at 73ºC for 15 seconds in a high-126 
temperature short-time pasteuriser (flow rate 300 L/h) using a plate heat exchanger. The milk 127 
was cooled to 32ºC and transferred to 100 L cheese vats. Starter culture (R 604, Chr. Hansen) 128 
was added (0.15 g/L) to the vat and allowed to ripen under stirring for 50 minutes. Enzyme 129 
(CHY-MAX, Chr. Hansen) was added (0.24 ml/L) and stirred for a further 3 minutes, before 130 
the stirrers were removed. Cutting time was 40 minutes after enzyme addition and was visually 131 
confirmed by the cheesemaker. The coagulum was cut by hand using coagulum cutting knives. 132 
Stirring commenced, and the temperature was increased slowly until it reached 38ºC; this 133 
scalding process continued for 1 h. Whey was subsequently drawn off the cheese vat. The 134 
resulting curd underwent a cheddaring process by piling and turning the curd 4 times. The curd 135 
was then milled using a cheese mill and dry salted (0.02 kg/kg) and placed into a stainless steel 136 
cheese mould. The mould was placed in a horizontal cheese press and pressed at 7 kPa 137 
overnight. The next day the cheese was vacuum packed and placed in an 8ºC ripening room 138 
for three months. After ripening, cheese was apportioned into 350 g, vacuum packed and stored 139 
at 2ºC.  140 
 141 
Butter processing. Conventional butter was provided by Arla Foods UK (Taw Valley 142 
Creamery) from winter butter stocks during P1 and P2. Modified P1 butter was manufactured 143 
at Reaseheath College (Nantwich, UK) and modified P2 butter was manufactured at Ty 144 
Tanglwyst Dairy (Bridgend, South Wales). Two batches of modified butter were manufactured 145 
in each period. In both cases the cream was separated from the milk using a disc bowl separator, 146 
pasteurised, and aged at 4ºC overnight. The cream was transferred to a churn and churned until 147 
butter grains were formed. The buttermilk was drained off and the butter grains were further 148 
worked to create a continuous emulsion. Salt was then added (1.7 g/100 g) and the butter was 149 
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further worked to ensure even distribution of the salt. The butter was apportioned into 250 g, 150 
packaged in butter wrap and stored at -20°C until required. 151 
 152 
Chemical analysis of milk and dairy products 153 
A sample of high oleic acid sunflower oil used during P1 and P2 and subsample of the TMR 154 
diet were analysed in duplicate for FA profile using a modified version of the one step 155 
transesterification method of Sukhija & Palmquist, (1988). Briefly, 50 mg oil or 300 mg TMR 156 
was incubated with an internal standard (methyl heneicosanoate, Sigma Aldrich Company Ltd., 157 
Dorset, UK) at 60°C in the presence of 0.4 M sulphuric acid in methanol and toluene as an 158 
extraction solvent, for 2 h (oil) or 3 h (TMR). Following neutralisation, the resulting fatty acid 159 
methyl esters (FAME) in toluene were allowed to stand over sodium sulphate for 30 min to 160 
remove methanol residues before being quantified by gas chromatography (GC; Bruker 350, 161 
Bruker, Germany). The GC was equipped with a flame ionisation detector and 100 m fused 162 
silica capillary column (CP-SIL 88, Agilent Technologies, Cheshire, UK), and GC conditions 163 
were as published previously (Kliem et al., 2013). Carbon deficiency in the flame ionization 164 
detector response for FAME containing 4- to 10-carbon atoms was accounted for using a 165 
combined correction factor which also converted FAME to FA (Ulberth et al., 1999). FA were 166 
quantified using internal standard peak area, and the results were also expressed as g/100 g FA. 167 
 168 
Samples of milk taken just prior to dairy product production (modified and conventional) were 169 
analysed for FA profile according to the method of Kliem et al. (2013). Briefly, lipid in 1 ml 170 
thawed, warmed (to 40°C) milk was extracted in duplicate using a mixture of diethyl ether and 171 
hexane (IDF 1: 2010 [E], International Dairy Federation, 2010, Brussels, Belgium) and extracts 172 
were transesterified to FAME according to previously described procedures (Kliem et al., 173 
2013). GC conditions and FAME identification were as described above. Methyl esters not 174 
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available as authentic standards were identified by gas chromatography-mass spectrometry 175 
(GC-MS; Thermo Trace GC coupled to ITQ 1100 mass spectrometer using helium as a carrier 176 
gas) analysis of 4, 4-dimethyloxazoline (DMOX) derivatives prepared from FAME. 177 
Preparation of DMOX derivatives and parameters used for GC-MS analysis were largely in 178 
accordance with earlier reports (Shingfield et al., 2006), however a split ratio of 1:14 was used 179 
for injection and the online reference library of DMOX electron impact ionisation spectra was 180 
http://lipidlibrary.aocs.org. The results were expressed as g/100 g FA. Lipid in 50 mg of 181 
conventional and modified butter was first warmed to 40°C before 1 ml distilled water (room 182 
temperature) added, and mixed vigorously to emulsify the butter fat. Extraction and 183 
methylation continued as with milk and the results were expressed as g/100 g total FA. The 184 
lipid in 3 g of conventional and modified cheese was firstly hydrolysed using 100 ml 3M HCl, 185 
and the resulting residue filtered through Whatman 1 filter paper prior to drying at 60°C for 18 186 
h. The lipid was extracted from the residue using petroleum ether (Brown & Mueller-Harvey, 187 
1999), and the amount of lipid calculated gravimetrically. The lipid was then gently warmed 188 
before 50 mg was transferred to clean glass tubes, and methylation of extracted FA was 189 
conducted as for milk and butter. 190 
  191 
Nutritional analysis (energy, protein, fat, carbohydrate, ash and moisture) of the dairy products 192 
from each cohort was conducted in duplicate by SGS United Kingdom Ltd. (ISO 17025 193 
accredited laboratory; Ellesmere Port, Cheshire, UK). To calculate protein content, the 194 
obtained nitrogen result was multiplied by the standard dairy nitrogen conversion factor (6.38) 195 
to account for the fraction of non-protein nitrogen in each sample (Maubois & Lorient, 196 
2016). Micronutrient content analysis (calcium, magnesium, sodium and phosphorus) was 197 
conducted in duplicate by inductively coupled plasma-optical emission spectrometry 198 
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(Quaternary Scientific [QUEST], University of Reading, Berkshire, UK). The results were 199 
expressed on a dry and fresh weight basis. 200 
 201 
Data analysis 202 
FA composition of all products was analysed using an ANOVA (Minitab17), and included 203 
effects of product type, production period, treatment, and period by treatment interactions. 204 
Product type was not significant for every FA, so it was removed from the model. Least squares 205 
means (± pooled standard error of the mean) are reported, and differences were considered 206 
significant at P < 0.01 to account for multiplicity. 207 
 208 
RESULTS 209 
The FA profile of the high oleic acid sunflower oil used during production P1 and P2 is 210 
presented in Table 2. There was a minimal change in FA profile during P2, when it contained 211 
a lower proportion of cis-9 18:1 and higher proportion of both 16:0 and 18:2 n-6.  212 
 213 
The micronutrient composition of the dairy products is presented in Table 3. Although 214 
differences between periods could not be statistically analysed due to sample size, there was 215 
numerically little difference between the two periods. 216 
 217 
The dairy product FA data presented are means across milk, cheese and butter. Lipid from 218 
modified dairy products had a lower (P<0.001) total SFA content than lipid from conventional 219 
dairy products, including a lower (12 g/100 g FA)  concentration of 16:0, but also all SFA ≤ 220 
14:0 including branched chain SFA such as 13:0 anteiso, 14:0 iso and 15:0 anteiso (Table 4). 221 
In contrast, the concentration of 18:0 was higher (P<0.001) in the modified dairy products. 222 
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There was no effect of production period on SFA content apart from 17:0 iso and 20:0 which 223 
were more abundant in P1 products (P<0.01). 224 
 225 
Treatment had an effect on both cis- and trans- MUFA (Table 4), with lipid from modified 226 
dairy products having a higher (P<0.001) concentration of both. Of the cis-MUFA, cis-9 18:1 227 
was the most abundant (Table 5), and concentration was at least 50 % greater in modified dairy 228 
compared with conventional products (Table 5). There were also notable differences in most 229 
of the other 18:1 isomers identified, modified products containing higher (P<0.05) lipid 230 
concentrations of cis-11, cis-13, trans-6-8, trans-9, trans-10, trans-12, trans-15 and trans-16 231 
18:1 (the predominant isomer switching from trans-11 18:1 in control products to trans-10 232 
18:1 in modified products). Aside from the 18:1 isomers, there were treatment differences in 233 
cis-9 10:1, cis-9 12:1, trans-9 14:1, cis-13 16:1 and cis-9 17:1, all of which were lower (P<0.01) 234 
in modified dairy products (Table 4).  235 
 236 
Total n-6 and n-3 PUFA concentrations were not different between lipid from conventional 237 
and modified products. In contrast, the concentration of total conjugated linoleic acid (CLA) 238 
isomers was greater (P=0.001) in modified products (Table 4). Of the non-methylene 239 
interrupted 18:2 isomers, cis-9, trans-13 18:2, cis-9, trans-14 18:2 and cis-9, trans-12 18:2 240 
were higher (P<0.01) in concentration in modified products (Table 6). There was an effect of 241 
period for cis-9, trans-13, which was more abundant (P<0.05) in P1 products (Table 6). 242 
 243 
DISCUSSION 244 
One of the main challenges of food chain interventions is to maintain a supply of the test food 245 
that is consistently different to the conventional product over the period of the study. The 246 
current study produced greater volumes of modified dairy products over a longer period of time 247 
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than other published studies (Livingstone et al., 2012). It has been reported previously that the 248 
milk FA profile resulting from supplementation with oilseeds can be affected by the chemical 249 
composition of other dietary constituents such as starch, or changes in DM intake (Lerch et al., 250 
2012a). Therefore, it is important to demonstrate that these strategies produce similar products 251 
over time, for the purposes of both controlled human dietary intervention studies, and also for 252 
future commercial application and consumer consumption. 253 
 254 
Overall there was little difference in most micronutrient contents of both the conventional and 255 
modified milk and dairy products, and this was the same over the two production periods. 256 
However, the modified milk had a low fat content (average 28 g/kg during period 1, 23 g/kg 257 
during period 2) prior to processing, which meant it was necessary to standardise the raw 258 
conventional milk prior to UHT so that the fat content matched that of the modified milk for 259 
the purposes of the human intervention study. Feeding unsaturated oils to dairy cows often 260 
suppresses milk fat concentration (Halmemies-Beauchet-Filleau et al., 2011), mainly due to 261 
the inhibitory effect of intermediates of rumen biohydrogenation on mammary FA synthesis 262 
(Bauman et al., 2011). In the current study, modified cheese was numerically lower (-5.6 g/100 263 
g) in fat content than the conventional cheese, probably due to the raw modified milk being 264 
lower in total fat. A study reporting the fat content of Mozzarella cheese made from milk where 265 
cows were fed incremental amounts of a linseed supplement reported no linear effect on cheese 266 
lipid content (Oeffner et al., 2013). In that study an extruded linseed supplement was fed, which 267 
may have afforded the constituent oil some degree of protection from rumen biohydrogenation. 268 
This suggests that a more suitable approach for production of modified milk on a commercial 269 
scale may be to use oilseed supplements that are protected from rumen biohydrogenation.  270 
 271 
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Despite being produced across two production periods, there was no effect of production period 272 
on the main FA in modified and conventional products. Decreases in milk fat concentrations 273 
of de novo-synthesised SFA and increases in 18:0 and cis-9 18:1 following oilseed 274 
supplementation were found to be comparable over two consecutive lactations, but changes in 275 
most trans-18:1 and 18:2 isomers varied depending on year (Lerch et al., 2012b). This was 276 
probably due to differences in starch contents of the experimental diets across the two years 277 
(Lerch et al., 2012a). Transient changes in concentration of certain CLA and trans-18:1 278 
isomers have been observed in response to oilseed supplementation over shorter periods of 279 
time (Roy et al., 2006). However the current study employed a dietary adaptation period of 4 280 
weeks prior to milk collection, which should have minimised any variation and successfully 281 
produced consistent modified milk essential for effective utilisation in the following human 282 
intervention study.  283 
 284 
There were differences in most individual FA concentrations between conventional and 285 
modified products. All short (4:0-10:0) and medium (12:0-16:0) chain SFA were lower in 286 
modified products, which was balanced by higher 18:0, cis-9 18:1 and intermediates of 287 
biohydrogenation concentrations which supports previous studies (Loor et al., 2002; Kliem et 288 
al., 2011). A meta-analysis of recent data reported that the majority of the milk SFA responses 289 
to plant oil supplements in dairy cow diets is due to decreases in 12:0, 14:0 and 16:0 290 
concentrations (Kliem & Shingfield, 2016). This can mainly be attributed to increases in the 291 
supply of ≥ 16 carbon FA leaving the rumen and inhibiting acetyl CoA carboxylase 292 
transcription and activity in the mammary gland (Barber et al., 1997). 293 
 294 
SFA in modified milk were mostly replaced with cis-9 18:1, which was the predominant FA in 295 
the oil supplement. The current study aimed to feed 1 kg oil/cow/day, which equated to around 296 
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800 g additional cis-9 18:1. In this unprotected oil form it would be expected that some rumen 297 
biohydrogenation of cis-9 18:1 would occur as has been reported in detailed in vivo studies 298 
(e.g. Loor et al., 2002), however there was a 10 g/100 g FA difference in cis-9 18:1 299 
concentration between conventional and modified products in the current study, in line with 300 
previous studies (Kliem et al., 2011). Milk fat cis-9 18:1 is derived from two sources – diet and 301 
endogenous desaturation of 18:0 by mammary epithelial cell ∆9-desaturase. One in vivo study 302 
estimated that this enzyme was responsible for almost 60 % of cis-9 18:1 present in milk fat 303 
(Mosley & McGuire, 2007). Dairy products from the current study contained a higher 304 
concentration of 18:0 than conventional products, which may have contributed to the increase 305 
in milk fat cis-9 18:1. 306 
 307 
A proportion of dairy SFA was also replaced by TFA, which are intermediates of rumen 308 
biohydrogenation of dietary unsaturated FA (Harfoot & Hazlewood, 1997). The majority of 309 
TFA identified in the current study were trans 18:1 isomers. In vitro studies have established 310 
that cis-9 18:1 is converted to a range of trans 18:1 isomers during incubation with rumen-311 
derived microorganisms (McKain et al., 2010). Furthermore, trans-9 18:1 has been shown to 312 
further isomerise during in vitro incubation with rumen bacteria to a range of positional trans 313 
18:1 isomers (Proell et al., 2002). The predominant isomer in the conventional dairy products 314 
was trans-11 18:1, but in the modified products, trans-10 18:1 predominated. Trans-10 18:1 is 315 
thought to arise as an intermediate of 18:2 n-6 biohydrogenation in response to changed rumen 316 
conditions on certain diets (Bauman et al., 2011), such as those which lower rumen pH 317 
(Palmquist et al., 2005). A recent review concluded that the predominance of trans-10 18:1 in 318 
ruminant products is more common than previously thought (Aldai et al., 2013), however very 319 
few milk-based studies have resulted in concentrations of trans-10 18:1 at the level observed 320 
in the current study. Roy et al. (2006) and Shingfield et al. (2005) both reported relatively high 321 
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concentrations of trans-10 18:1 in milk fat after feeding oilseed supplements (18 and 13 g/100 322 
g total FA, respectively), with suggested possible reasons being increased supply of 18:2 n-6 323 
and low rumen pH. In the current study, 18:2 n-6 content of the oil was low, so the high trans-324 
10 18:1 content of modified milk would have been primarily due to isomerisation of cis-9 18:1 325 
within the rumen. This was suggested after a similar effect was observed when olive oil (high 326 
in cis-9 18:1) was fed to dairy sheep (Gomez-Cortes et al., 2008). Trans-10 18:1 has often been 327 
thought partially responsible for milk fat depression, but studies involving abomasally-infused 328 
trans-10 18:1 have reported inconsistent results (Lock et al., 2006; Shingfield et al., 2009)  329 
 330 
Enriched concentrations of CLA in milk are usually due to an increased supply of 18:2 n-6 or 331 
18:3 n-3 to the rumen, biohydrogenation of which results in increased trans-11 18:1 available 332 
to mammary ∆9 desaturase and therefore increased cis-9, trans-11 CLA, the predominant 333 
isomer (Palmquist et al., 2005). In the current study modified products had a higher overall 334 
CLA concentration than conventional products, but there was no difference in trans-11 18:1. 335 
Either desaturation of trans-11 18:1 was extremely efficient, or the increase in CLA 336 
concentration observed was due to increases in other CLA isomers.  337 
 338 
The observed difference in SFA and MUFA content between conventional and modified 339 
products is comparable to that of previous studies (Livingstone et al., 2012). However few 340 
previous studies reported a detailed FA profile. The studies of Tholstrup et al. (2006) and 341 
Lacroix et al. (2012) were specifically designed to observe the effects of increased ruminant-342 
derived TFA, and as such the modified products contained enriched concentrations of trans-11 343 
18:1 in particular. The current study reported a greater concentration of trans-10 18:1 in 344 
modified products and the potential for these TFA to impact on CVD risk factors remains to 345 
be investigated.  346 
15 
 
 347 
CONCLUSIONS 348 
In conclusion, feeding a specially formulated diet containing a high oleic acid sunflower oil to 349 
dairy cows over two production periods resulted in dairy products with the same FA profile, 350 
lower in SFA (including 12:0, 14:0 and 16:0), and higher in cis- and trans-MUFA (particularly 351 
cis-9 18:1 and trans-10 18:1) than conventionally-produced dairy products. Processing the 352 
modified milk into UHT milk, butter and Cheddar cheese had minor effects on FA profile. This 353 
technique is therefore suitable for the production of modified dairy products, to replicate the 354 
FA profile, suitable for use in large-scale human intervention studies, where composition 355 
consistency is required over a longer period of time (as is required to assess effects on CVD 356 
risk markers). This technique may also suitable for production of modified dairy foods on a 357 
commercial scale, although the effect of this dietary strategy on milk fat content should be 358 
considered.  359 
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Table 1. Ingredients and analysed chemical composition of the cow diet used during 514 
production period 1 (g/kg dry matter (DM) or as stated) 515 
 g/kg DM 
Ingredients  
    Maize silage 350 
    Grass silage 52 
    Grass hay 33 
    Straw 33 
    Wheat by-product1 86 
    Concentrate mix2 372 
    Calcium salts of palm oil distillate3 11 
    Salt4 4 
    Limestone 4 
    Minerals and vitamins 11 
    High oleic acid sunflower oil5 43 
Chemical composition  
    DM (g/kg fresh) 515 
    Organic matter 932 
    Crude protein 144 
    Neutral detergent fibre 351 
    Acid detergent fibre 199 
    Starch 212 
    Oil 70.0 
    ME (MJ/kg DM)6 12.6 
Fatty acids  
    16:0 2.9 
    18:0 0.9 
    18:1 cis-9 14.6 
    18:2 n-6 6.1 
    18:3 n-3 0.05 
1CTraffordgold®; KW Alternative Feeds Ltd., Barrow Hill Barns, Andover, SP11 7RG, UK  516 
2 Containing (g/kg DM): Cracked wheat, 180; Soyabean meal 160; Rapeseed meal, 175; 517 
Sugar beet feed, 140; Wheat distillers, 140; Soya hulls, 120; Molasses, 33; Megalac®, 17; 518 
Urea, 11; Minerals [KW Alternative Feeds Ltd., Barrow Hill Barns, Andover, SP11 7RG, 519 
UK], 22).  520 
3 Megalac®; Volac International Ltd., Royston, Hertfordshire, SG8 5QX, UK 521 
4 Dairy Direct, Church Farm, Bury St Edmunds, IP28 6PX, UK. 522 
5AAK (UK) Ltd., Hull, East Yorkshire, HU9 5PX, UK. 523 
 524 
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Table 2. Fatty acid composition of the high oleic acid sunflower oil used during the two 525 
production periods (g/100 g total fatty acids) 526 
Fatty acid Production period 1 Production period 2 
16:0 3.6 4.1 
18:0 3.1 2.7 
18:1 cis-9 82.1 80.4 
18:2 n-6 7.5 10.1 
18:3 n-3 0.26 0.27 
 527 
 528 
 529 
 530 
 531 
 532 
 533 
 534 
 535 
 536 
 537 
 538 
 539 
 540 
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Table 3. Micronutrient composition of the modified and conventional dairy products (average across production periods 1 and 2; units as stated, 541 
means ± product s.e.m.) 542 
 UHT milk  Butter  Cheddar cheese 
 Conventional Modified s.e.m.  Conventional Modified s.e.m.  Conventional Modified s.e.m. 
Energy (kJ/100 g) 220 232 6.5  3037 3024 12.1  1688 1527 46.5 
Energy (kcal/100 g) 52.5 55.4 1.56  739 735 2.9  407 368 11.4 
Total carbohydrate (g/100 g) 4.4 4.7 0.09  1.93 0.98 0.332  3.1 2.6 0.22 
Ash (g/100 g) 0.72 0.77 0.014  1.8 1.6 0.08  4.0 3.9 0.09 
Moisture (g/100 g) 88.8 88.3 0.20  14.9 16.0 0.37  36.2 39.2 0.92 
Nitrogen (g/100 g) 0.47 0.51 0.015  0.04 0.07 0.011  3.7 4.2 0.16 
Protein (g/100 g)1 3.0 3.3 0.09  0.23 0.44 0.070  23.1 26.4 1.00 
Fat (g/100 g) 2.5 2.6 0.14  81.1 81.1 0.37  33.6 28.0 1.62 
25 
 
Calcium (mg/100 g dry) 1147 1090 21.9  19.1 20.6 1.60  1242 1428 87.7 
               (mg/100 g fresh) 126 119 4.5  17.0 17.9 1.33  801 911 47.0 
Magnesium (mg/100 g dry) 105 101 1.3  2.1 2.1 0.10  46.6 47.4 0.72 
                    (mg/100 g fresh) 11.5 11.1 0.32  1.9 1.8 0.09  30.1 30.3 0.52 
Sodium (mg/100 g dry) 378 417 17.8  795 577 72.6  1123 1187 59.3 
              (mg/100 g fresh) 41.4 45.5 2.18  707 502 66.9  726 760 43.1 
Phosphorus (mg/100 g dry) 896 819 27.5  25.4 27.0 1.73  836 939 51.9 
                    (mg/100 g fresh) 98.1 89.2 3.66  22.6 23.5 1.43  539 599 27.0 
1Calculated by nitrogen conversion factor 6.38 (Maubois & Lorient, 2016) 543 
 544 
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Table 4. Mean fatty acid composition of the lipid from all modified and conventional dairy products over two production periods (g/100 g total 545 
fatty acids, least squares means for milk, butter and cheese ± s.e.m.) 546 
 Period 1  Period 2 s.e.m.1 P2 
 Conventional Modified  Conventional Modified  Production 
period 
Treatment Interaction 
4:0 2.9 2.2  2.9 2.1 0.06 0.668 <0.001 0.124 
6:0 1.8 1.1  1.9 1.0 0.04 0.732 <0.001 0.057 
8:0 1.11 0.62  1.14 0.54 0.030 0.420 <0.001 0.088 
10:0 2.7 1.5  2.8 1.2 0.07 0.056 <0.001 0.033 
10:1 cis-9 0.28 0.13  0.29 0.13 0.011 0.727 <0.001 0.547 
11:0 0.053 0.004  0.025 0.002 0.0138 0.329 0.031 0.375 
12:0 3.5 2.0  3.5 1.6 0.13 0.194 <0.001 0.133 
12:1 cis-9 0.10 0.05  0.10 0.05 0.005 0.893 <0.001 0.453 
13:0 0.10 0.05  0.09 0.05 0.010 0.601 0.003 0.859 
13:0 anteiso 0.09 0.06  0.09 0.05 0.004 0.618 <0.001 0.418 
14:0 11.3 8.5  11.4 7.4 0.30 0.188 <0.001 0.077 
27 
 
14:0 iso 0.08 0.07  0.09 0.07 0.005 0.669 0.008 0.842 
14:1 cis-9 1.02 0.95  1.04 1.01 0.041 0.366 0.231 0.663 
14:1 trans-9 0.22 0.16  0.24 0.17 0.010 0.210 <0.001 0.686 
15:0 1.10 0.71  1.14 0.71 0.038 0.613 <0.001 0.585 
15:0 anteiso 0.43 0.38  0.42 0.35 0.008 0.021 <0.001 0.406 
16:0 33.3 20.9  33.8 22.2 0.69 0.220 <0.001 0.602 
16:0 iso 0.20 0.19  0.20 0.20 0.010 0.650 0.721 0.629 
16:1 cis-9 + 17:0 anteiso 1.7 1.6  1.5 1.5 0.07 0.050 0.596 0.340 
16:1 cis-11 0.21 0.13  0.42 0.40 0.065 0.007 0.516 0.651 
16:1 cis-13 0.15 0.05  0.17 0.05 0.011 0.412 <0.001 0.417 
16:1 trans-9 0.03 0.10  0.10 0.05 0.101 0.377 0.001 0.640 
17:0 iso 0.33 0.36  0.29 0.31 0.012 0.008 0.073 0.588 
17:0 0.48 0.36  0.49 0.33 0.005 0.090 <0.001 0.013 
17:1 cis-9 0.20 0.16  0.20 0.15 0.003 0.333 <0.001 0.089 
18:0 9.6 14.0  9.4 13.0 0.32 0.089 <0.001 0.217 
18:0 iso 0.03 0.02  0.06 0.03 0.008 0.026 0.019 0.026 
28 
 
∑ 18:1 trans 2.8 9.4  2.6 10.2 0.30 0.348 <0.001 0.130 
∑ 18:1 cis 20.0 29.6  19.3 30.3 0.74 0.994 <0.001 0.407 
∑ CLA3 0.57 0.71  0.59 0.98 0.065 0.195 0.001 0.025 
∑ NMI4 18:2 2.1 2.3  2.1 2.5 0.17 0.605 0.084 0.857 
18:3 n-3 0.32 0.23  0.40 0.30 0.032 0.060 0.020 0.872 
19:05 0.10 0.10  0.08 0.08 0.016 0.326 0.970 0.966 
20:0 0.15 0.15  0.14 0.13 0.003 0.009 0.063 0.118 
20:1 cis-9 0.10 0.10  0.09 0.08 0.009 0.130 0.604 0.394 
20:1 cis-11 0.09 0.09  0.02 0.01 0.045 0.108 0.802 0.883 
20:2 n-6 0.005 0.008  0.012 0.005 0.0066 0.771 0.719 0.447 
20:3 n-6 0.06 0.07  0.07 0.06 0.008 0.634 0.255 0.918 
20:4 n-6 0.10 0.07  0.10 0.06 0.007 0.625 0.001 0.300 
20:5 n-3 0.05 0.01  0.05 0.02 0.008 0.488 0.002 0.321 
22:0 0.05 0.08  0.05 0.08 0.007 0.851 0.003 0.370 
22:2 n-6 0.020 0.006  0.034 0.003 0.0119 0.727 0.082 0.554 
22:5 n-3 0.08 0.04  0.08 0.04 0.009 0.582 0.002 0.717 
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24:0 0.02 0.03  0.04 0.04 0.008 0.189 0.478 0.531 
∑ SFA6 70.3 54.3  70.9 52.2 0.97 0.479 <0.001 0.204 
∑ cis-MUFA7 23.0 32.2  22.5 32.9 0.67 0.932 <0.001 0.372 
∑ trans-MUFA7 3.3 10.0  3.2 10.8 0.29 0.268 <0.001 0.125 
∑ trans fatty acids 4.0 10.7  3.8 11.8 0.31 0.208 <0.001 0.082 
∑ n-3 PUFA8 0.63 0.48  0.72 0.59 0.054 0.096 0.033 0.791 
∑ n-6 PUFA8 1.7 1.9  1.9 2.0 0.18 0.547 0.578 0.865 
1 Standard error of the mean for n=12 measurements 547 
2 Refers to the significance of overall effect of period, treatment and their interaction 548 
3 CLA – conjugated linoleic acid 549 
4 NMI - non methylene-interrupted 550 
5 Co-elutes with 18:1 cis-15 551 
6 SFA – saturated fatty acids 552 
7 MUFA – monounsaturated fatty acids 553 
8 PUFA – polyunsaturated fatty acids  554 
 555 
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Table 5. Mean 18:1 isomer composition of the lipid from all modified and conventional dairy products over two production periods (g/100 g 556 
total fatty acids, least squares means for milk, butter and cheese ± s.e.m.) 557 
 Period 1  Period 2 s.e.m.1 P2 
 Conventional Modified  Conventional Modified  Production 
period 
Treatment Interaction 
cis-9 18:13 18.8 28.2  18.4 28.9 0.72 0.859 <0.001 0.439 
cis-11 18:1 0.61 0.81  0.44 0.70 0.048 0.023 0.001 0.522 
cis-12 18:1 0.22 0.16  0.21 0.19 0.016 0.467 0.042 0.318 
cis-13 18:1 0.09 0.16  0.08 0.11 0.017 0.103 0.017 0.364 
cis-16 18:1 0.06 0.06  0.05 0.04 0.005 0.091 0.454 0.294 
trans-6, -7, -8 18:1 0.24 1.28  0.24 1.25 0.290 0.955 0.008 0.961 
trans-9 18:1 0.20 0.94  0.18 1.39 0.119 0.102 <0.001 0.082 
trans-10 18:1 0.36 4.01  0.41 2.49 0.413 0.113 <0.001 0.095 
trans-11 18:1 1.10 0.94  0.85 1.81 0.428 0.490 0.375 0.227 
trans-12 18:1 0.38 1.01  0.32 1.09 0.065 0.816 <0.001 0.310 
trans-15 18:1 0.40 0.94  0.47 1.82 0.231 0.074 0.004 0.119 
31 
 
trans-16 18:14 0.31 0.35  0.31 0.48 0.024 0.023 0.003 0.026 
 558 
1 Standard error of the mean for n=12 measurements 559 
2 Refers to the significance of overall effect of period, treatment and their interaction 560 
3 Co-elutes with 18:1 trans-13/14 561 
4 Co-elutes with 18:1 cis-14. 562 
 563 
 564 
 565 
 566 
 567 
 568 
 569 
 570 
 571 
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Table 6. Mean non-methylene-interrupted 18:2 isomer composition of the lipid from all modified and conventional dairy products over two 572 
production periods (all values as mg/100 g total fatty acids, least square means for milk, butter and cheese ± s.e.m.) 573 
 Period 1  Period 2 s.e.m.1 P2 
 Conventional Modified  Conventional Modified  Production 
period 
Treatment Interaction 
cis-9, trans-13 18:2 182 238  177 334 11.4 0.004 <0.001 0.002 
cis-10, trans-14 18:2 122.6 122.6  100.0 92.1 9.12 0.020 0.679 0.680 
cis-9, trans-14 18:2 80.4 100.8  75.4 107.9 5.83 0.861 0.002 0.330 
cis-9, trans-12 18:2 33.7 50.4  26.9 54.0 3.78 0.697 <0.001 0.206 
trans-9, cis-12 18:2 7.5 8.2  46.0 15.5 10.80 0.067 0.205 0.187 
trans-11, cis-15 18:2 122.5 105.5  66.7 134.4 23.56 0.585 0.312 0.110 
cis-9, cis-12 18:2 1449 1629  1563 1686 141.3 0.561 0.316 0.845 
1 Standard error of the mean for n=12 measurements 574 
2 Refers to the significance of overall effect of period, treatment and their interaction 575 
 576 
